CDX2 and neoplasm: Furthermore, viable tumor areas were scored as being poorly, moderately, and/or well differentiated in a blinded fashion by a pathologist, revealing statistically significant differences between control and CDX2 knockdown xenograft tumors (Figure 3G and Supplemental Figure 4D).